Céline Lemaire

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook, Howard Kynaston et autres

gb, ca, dk (code pays fourni par la source)

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Timothy J. Whelan, Jim A. Julian, Tanya Berrang, Do‐Hoon Kim et autres

ca, au (code pays fourni par la source)

Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial

Abdenour Nabid, Nathalie Carrier, André‐Guy Martin, Jean-Paul Bahary et autres

ca (code pays fourni par la source)

Causes of death in localised prostate cancer: Long term data from two phase III trials

Abdenour Nabid, Nathalie Carrier, Éric Vigneault, Céline Lemaire et autres

Significance of Testosterone Suppression in Localized Prostate Cancer Treated with Androgen Deprivation Therapy and Radiotherapy: Data from 2 Phase 3 Trials

Abdenour Nabid, Gratacap Marie-Pierre, É. Vigneault, Luís Souhami et autres

ca (code pays fourni par la source)

Duration of androgen deprivation therapy in high risk prostate cancer: Final results of a randomized phase III trial.

Abdenour Nabid, Marie‐Pierre Garant, André‐Guy Martin, Jean-Paul Bahary et autres

ca (code pays fourni par la source)

Does nadir testosterone at the end of long term androgen deprivation therapy predict outcomes in high risk prostate cancer? Data from a phase III trial

Abdenour Nabid, Marie‐Pierre Garant, A. González Martín, Luís Souhami et autres

Is there a relationship between testosterone levels at the end of short-term androgen deprivation therapy and outcomes in intermediate risk prostate cancer? Prospective data from a phase III trial.

Abdenour Nabid, Marie‐Pierre Garant, Éric Vigneault, Luís Souhami et autres

ca (code pays fourni par la source)

Second Malignancies as First Cause of Death in Localized Prostate Cancer Treated With Radiation Therapy: Data from Two Phase 3 Trials

Abdenour Nabid, Nathalie Carrier, Éric Vigneault, Luís Souhami et autres

ca (code pays fourni par la source)

59 Second primary tumors in prostate cancer: Data from two phase III trials

Abdenour Nabid, Nathalie Carrier, Éric Vigneault, A. González Martín et autres

Causes of death in intermediate- and high-risk prostate cancer treated with radiotherapy with or without androgen deprivation therapy: Analysis from two phase III trials.

Abdenour Nabid, Nathalie Carrier, Éric Vigneault, André‐Guy Martin et autres

ca (code pays fourni par la source)

Radiation Therapy With or Without Short-Term Androgen Deprivation Therapy in Intermediate-Risk Prostate Cancer: Results of a Phase 3 Trial

Abdenour Nabid, Nathalie Carrier, Éric Vigneault, Luís Souhami et autres

ca (code pays fourni par la source)